BP
BioPharma Credit PLC (BPCP)
LSE
73.20
+1.70 (+2.38%)
Real-time Data
07:00 AM
Day's Range
70.6073.20
52 wk Range
0.642274.20
Financial Statements - BPCP - BioPharma Credit PLC
Revenue
132.05M▲ 6.1%
Net Income
129.88M▲ 6.3%Net Margin 98.4%
Free Cash Flow
91.09M▼ 18.6%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 132.05M | 124.45M | 110.48M | 184.24M | 87.96M | 91.35M |
| Cost of Goods | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | - | - | - | - | - | - |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - | - |
| Pre Tax Income | 129.88M | 122.17M | 108.45M | 182.31M | 84.95M | 89.13M |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | 129.88M | 122.17M | 108.45M | 182.31M | 84.95M | 89.13M |
| EPS Basic | - | 0.0999 | 0.0828 | 0.1336 | 0.0618 | 0.0649 |
| EPS Diluted | - | 0.0999 | 0.0828 | 0.1336 | 0.0618 | 0.0649 |
| Basic Shares Outstanding | - | 1.22B | 1.30B | 1.36B | 1.37B | 1.37B |
| Diluted Shares Outstanding | - | 1.22B | 1.30B | 1.36B | 1.37B | 1.37B |
| Ebit | - | - | - | - | - | - |
| Ebitda | - | - | - | - | - | - |
| Net Income Continuous Operations | 129.88M | 122.17M | 108.45M | 182.31M | 84.95M | 89.13M |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
